Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 43: 745-751, 1997;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fortina, P.
Right arrow Articles by Wilding, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fortina, P.
Right arrow Articles by Wilding, P.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Pediatric Clinical Chemistry
(Clinical Chemistry. 1997;43:745-751.)
© 1997 American Association for Clinical Chemistry, Inc.

Articles

Diagnosis of Duchenne/Becker muscular dystrophy and quantitative identification of carrier status by use of entangled solution capillary electrophoresis

Paolo Fortina1,a, Jing Cheng, Mann A. Shoffner, Saul Surrey1, Wendy M. Hitchcock2, Larry J. Kricka and Peter Wilding

1 Department of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA.

2 Department of Pathology and Clinical Laboratories, The Children's Hospital of Philadelphia.
a Address correspondence to this author, at: The Children's Hospital of Philadelphia, 310-C Abramson Pediatric Research Center, 34th St. and Civic Center Blvd., Philadelphia, PA 19104-4318. Fax 215-590-3660; e-mail fortina{at}mail.med.upenn.edu

Use of capillary electrophoresis, a new and useful analytical tool, offers a variety of advantages for nucleic acid analyses, including rapid analysis, automation, high resolution, qualitative and quantitative results, and low consumption of both sample and reagents. We report the first example of the use of entangled solution capillary electrophoresis (ESCE) and laser-induced fluorescence detection (LIF) for separation-based diagnostics in the quantitative analysis of multiplex PCR products for determination of carrier status of Duchenne/Becker muscular dystrophy (DMD/BMD). This ap-proach greatly improved the speed, resolution, and sensitivity of information needed for the diagnosis of DMD/BMD compared with that from conventional diagnostic methods, and is of general utility for diagnosis of genetic diseases.


Key Words: indexing terms: polymerase chain reaction • heritable disorders • laser-induced fluorescence detection




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
C.-C. Hung, Y.-N. Su, C.-Y. Lin, C.-C. Yang, W.-T. Lee, S.-C. Chien, W.-L. Lin, and C.-N. Lee
Denaturing HPLC Coupled with Multiplex PCR for Rapid Detection of Large Deletions in Duchenne Muscular Dystrophy Carriers
Clin. Chem., July 1, 2005; 51(7): 1252 - 1256.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. Frisso, A. Carsana, N. Tinto, G. Calcagno, F. Salvatore, and L. Sacchetti
Direct Detection of Exon Deletions/Duplications in Female Carriers of and Male Patients with Duchenne/Becker Muscular Dystrophy
Clin. Chem., August 1, 2004; 50(8): 1435 - 1438.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. Ferrance, K. Snow, and J. P. Landers
Evaluation of Microchip Electrophoresis as a Molecular Diagnostic Method for Duchenne Muscular Dystrophy
Clin. Chem., February 1, 2002; 48(2): 380 - 383.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
B. Costes, E. Girodon, D. Vidaud, E. Flori, A. Ardalan, P. Conteville, P. Fanen, F. Niel, M. Vidaud, and M. Goossens
Prenatal Detection by Real-Time Quantitative PCR and Characterization of a New CFTR Deletion, 3600+15kbdel5.3kb (or CFTRdele19)
Clin. Chem., September 1, 2000; 46(9): 1417 - 1420.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Gelfi, M. Perego, P. G. Righetti, S. Cainarca, S. Firpo, M. Ferrari, and L. Cremonesi
Rapid capillary zone electrophoresis in isoelectric histidine buffer: high resolution of the poly-T tract allelic variants in intron 8 of the CFTR gene
Clin. Chem., May 1, 1998; 44(5): 906 - 913.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. J. O'Kane, T. A. Ebert, B. J. Hallaway, S. G. Roberts, A. K. M. J. Bhuiyan, and K. S. Tenner
A laboratorian's perspective on evaluation and implementation of new laboratory tests
Clin. Chem., September 1, 1997; 43(9): 1771 - 1780.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.